Copaxone is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Neuroscience, Inc.. The primary component is Glatiramer Acetate.
Product ID | 68546-317_04f9ea25-0d45-4e44-8ed8-dc61db4f5466 |
NDC | 68546-317 |
Product Type | Human Prescription Drug |
Proprietary Name | Copaxone |
Generic Name | Glatiramer Acetate |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2008-04-28 |
Marketing Category | NDA / NDA |
Application Number | NDA020622 |
Labeler Name | Teva Neuroscience, Inc. |
Substance Name | GLATIRAMER ACETATE |
Active Ingredient Strength | 20 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2008-04-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020622 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-06-04 |
Marketing End Date | 2015-02-28 |
Marketing Category | NDA |
Application Number | NDA020622 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-04-28 |
Ingredient | Strength |
---|---|
GLATIRAMER ACETATE | 20 mg/mL |
SPL SET ID: | aa88f583-4f5f-433b-80b4-1f4c9fb28357 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
68546-317 | Copaxone | Glatiramer Acetate |
68546-325 | Copaxone | Glatiramer Acetate |
0378-6960 | Glatiramer Acetate | glatiramer acetate |
0781-3234 | Glatopa | Glatiramer Acetate |
0781-3250 | Glatopa | Glatiramer Acetate |
63629-8815 | Glatopa | Glatiramer Acetate |
63629-8816 | Glatopa | Glatiramer Acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
COPAXONE 74348964 1816603 Live/Registered |
TEVA PHARMACEUTICAL INDUSTRIES LTD. 1993-01-15 |